Cepheid Logo
Request Info
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}
{{initials}}
Main Menu
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info
Request Info

Xpert® SA Nasal Complete

Order & Support
S. aureus and MRSA (Nasal Complete) computer generated depiction.
Detection of S. aureus and MRSA in about 65 minutes

The Need

an ill woman listens to a physician
  • Up to 30% of the population is asymptomatically colonized with S. aureus1
  • S. aureus colonization is associated with an increased risk of severe infections, including surgical‑site and non‑surgical infections, which contribute to increased morbidity and mortality1
  • Perioperative therapeutic strategies vary depending on colonization of MRSA or MSSA2
1 Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front Microbiol. 2018 Oct 8;9:2419. doi: 10.3389/fmicb.2018.02419. PMID: 30349525; PMCID: PMC6186810.
2 Schweizer ML, Chiang H, Septimus E, et al. Association of a Bundled Intervention With Surgical Site Infections Among Patients Undergoing Cardiac, Hip, or Knee Surgery. JAMA. 2015;313(21):2162–2171. doi:10.1001/jama.2015.5387

The Solution

a male and a female researchers scanning cepheid test cartridges
  • Xpert SA Nasal Complete is a qualitative in vitro diagnostic test designed for the detection of S. aureus and methicillin-resistant S. aureus (MRSA) from nasal swabs in patients at risk for nasal colonization
  • Identification of S. aureus nasal carriers can support implementation of infection control strategies
3 Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17
* Xpert SA Nasal Complete compared to Reference Culture: (Enriched Blood Agar). Refer to Package Insert 300-8799 Rev. H

The Impact

a smiling female doctor attends an elderly woman
  • Reliable detection of S. aureus and MRSA supports infection control and surveillance activities in healthcare settings4
  • Published studies have demonstrated that MRSA infections are associated with increased healthcare costs5
  • Minutes of hands-on time with results in about 1 hour on a random-access platform
4 Klein EY, Zhu X, Petersen M, Patel EU, Cosgrove SE, Tobian AAR. Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Hospitalizations: National Inpatient Sample, 2016-2019. Open Forum Infect Dis. 2021 Nov 22;9(1):ofab585. doi: 10.1093/ofid/ofab585. PMID: 34988254; PMCID: PMC8715851.
5 Anderson, DJ. Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study. PLOS One. 2009 Dec 15. Accessed May 2020. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008305

Connect To Better Outcomes

Request Info

Insights

Get More Insights